bioinformatics jobs, bioinformatics career, what is bioinformatics, biotech companies, pharmaceutical companies, etc.

::Bioinformatics Resources::

Home | News | Companies | Tutorials | Books | Jobs | Directory | What's Bioinformatics | Bioinformatics FAQ
Bioinformatics News Archive
Sep 2010 | Aug 2010 | Jul 2010 | Jun 2010 | May 2010 | Apr 2010 | Mar 2010 | Feb 2010 | Jan 2010 | Dec 2009 | Nov 2009 | Oct 2009 | Sep 2009 | Aug 2009 | Jul 2009 | Jun 2009 | May 2009 | Apr 2009 | Mar 2009 | Feb 2009 | Jan 2009 | Dec 2008 | Nov 2008 | Oct 2008 | Sep 2008 | Aug 2008 | Jul 2008 | Jun 2008 | May 2008 | Apr 2008 | Mar 2008 | Feb 2008 | Jan 2008 | Dec 2007 | Nov 2007 | Oct 2007 | Sep 2007 | Aug 2007 | Jul 2007 | Jun 2007 | May 2007 | Apr 2007 | Mar 2007 | Feb 2007 | Jan 2007 | Dec 2006 | Nov 2006 | Oct 2006 | Sep 2006 | Aug 2006 | Jul 2006 | Jun 2006


Bioinformatics News Feb 2007

1 2 3 4 Next

Announcing the Bioinformatics Franklin Award Nominees
January 31, 2007 | The Bioinformatics Organization has nominated four leading American scientists for the 2007 Benjamin Franklin Award. This year’s nominees are: (Thu, 01 Feb 2007 02:08:14 GMT)

Bio-IT Briefs
January 29, 2007 | Covance will open a dedicated central laboratory in Shanghai, China, to further strengthen the company's global network of full-service central laboratories and meet the growing demand for clinical trials conducted in China. (Thu, 01 Feb 2007 02:11:09 GMT)

Australia February 1, 2007
Two recently discovered genes from an ancient wheat variety have led to a major advance in breeding new salt-tolerant varieties. (Thu, 01 Feb 2007 04:24:36 GMT)

Rochester lays seige to Capitol
ST. PAUL -- People of all ages enlivened the staid confines of the Capitol on Wednesday with feasting and political chants during the fourth-annual Rochester on Tour at the Capitol (Thu, 01 Feb 2007 05:30:49 GMT)

Compugen-Teva Deal: Lessons For Investors
Shlomo Greenberg submits: A lesson in investor behavior can learned from the stock of Compugen . It reached $3.20 in mid-November, and has since fallen 20% to $2.50. Over the last week it began a revival, which culminated in Tuesday's colossal jump after the company announced that it had signed an agreement with Teva Pharmaceutical [... ] (Thu, 01 Feb 2007 08:10:44 GMT)

Proposed U.S. farm bill may benefit California
Conservation programs and organic goods stand to profit as funds shift from traditional crops. WASHINGTON — In a potential windfall for California farmers, the Bush administration proposed a farm bill Wednesday that would boost spending for conservation, organic crops, and fruit and vegetable producers. (Thu, 01 Feb 2007 08:11:13 GMT)

Althea Technologies and Blueshift Biotechnologies Combine Technologies for High Throughput, Gene Expression Screening
Althea Technologies, Inc. and Blueshift Biotechnologies announced today that Althea has received a SBIR award from the National Human Genome Research Institute to explore the potential for practical high throughput and low cost gene expression analysis. The grant proposes the development of gene expression profiling methods that make use of Althea's proprietary strength in multiplexed PCR* ... (Thu, 01 Feb 2007 11:00:00 GMT)

Money fuels next wave of innovation
Venture capital was down last year in O.C. Here's how some medical companies are spending what they got. (Thu, 01 Feb 2007 11:05:43 GMT)

Research facility goes to Berkeley
International energy giant BP LLC is expected this morning to announce selection of a Bay Area team for a half-billion dollar institute devoted to cutting-edge research on biological fuels. (Thu, 01 Feb 2007 11:23:05 GMT)

Stratagene Expects Fourth Quarter Revenue of Approximately $24.7 Million
LA JOLLA, Calif.----Stratagene Corporation , a developer, manufacturer and marketer of specialized life science research and diagnostic products, today announced preliminary revenue results for the fourth quarter of 2006 ended December 31, 2006. (Thu, 01 Feb 2007 11:30:00 GMT)

Molecular Devices Reports Revenues and Earnings for the Quarter and Year Ended December 31, 2006
Molecular Devices Corporation today announced revenues and earnings for the quarter and year ended December 31, 2006. (Thu, 01 Feb 2007 13:00:00 GMT)

Affymetrix to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
SANTA CLARA, Calif.----Affymetrix, Inc. today announced it will webcast its presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City at 3:20 p.m. (Thu, 01 Feb 2007 14:00:00 GMT)

Affymetrix to Host Conference Call on February 7, 2007 to Announce Fourth Quarter and Fiscal Year 2006 Results
SANTA CLARA, Calif.----Affymetrix, Inc. today announced that it will release results for the fourth quarter and fiscal year 2006 after close of the stock market on Wednesday, February 7, 2007. (Thu, 01 Feb 2007 14:00:00 GMT)

UB to expand near downtown Buffalo medical campus
The University at Buffalo's master plan will mean a significant investment and presence in downtown Buffalo, officials say. (Thu, 01 Feb 2007 14:01:56 GMT)

New forecasting tool could reduce drug development costs
It now costs more than $800 million to develop a new drug. (Thu, 01 Feb 2007 14:07:32 GMT)

New Forecasting Tool Could Reduce Drug Development Costs
It now costs over $800 million to develop a new drug. But what if drug companies could predict which new drugs will get FDA approval and which will fail? Researchers present an analytical model that could save hundreds of millions of dollars per new drug, and urge more data sharing by the drug industry to improve forecasting, so that more medical discoveries can be brought to the bedside. (Thu, 01 Feb 2007 15:21:13 GMT)

Helicos BioSciences Validates Commitment to Bioinformatics with Most Recent Addition to Scientific Advisory Board
CAMBRIDGE, Mass.----Helicos BioSciences, pioneering new frontiers in genetic analysis, today announced the addition of Eugene Myers, Ph.D. of the Janelia Farm Research Campus of the Howard Hughes Medical Institute in Ashburn, Virginia, to its scientific advisory board. (Thu, 01 Feb 2007 15:30:00 GMT)

Agilent Technologies Named Instrument Business Outlook's 2006 Company of the Year
SANTA CLARA, Calif.----Influential technical instruments newsletter Instrument Business Outlook has named Agilent Technologies as its 2006 Company of the Year. The award recognizes noteworthy achievements of Agilent's life sciences and chemical analysis business. (Thu, 01 Feb 2007 16:00:00 GMT)

Grafts against cancer
A research team led by Prof. Claude Perreault, Université de Montréal, is announcing a major discovery in Genomics. This will generate a fundamental impact on the treatment of blood cancers (leukemias and lymphomes) by means of peripheral blood T-cell grafts. (Thu, 01 Feb 2007 16:12:47 GMT)

Lockheed Martin Completes Acquisition of Management Systems Designers Incorporated
Lockheed Martin Corporation has completed its acquisition of Management Systems Designers Incorporated , a Fairfax, Virginia-based provider of information technology and scientific solutions supporting government life science, national security, and other civil agency missions. (Thu, 01 Feb 2007 19:08:00 GMT)

DuPont to Open India Facility by 2008
DuPont said Thursday it plans on building a research and development center in India at a cost of about $22.5 million. The company said it signed a memorandum of understanding with ICICI Knowledge Park in Hyderabad, India, for a long-term lease that will give the company 15 acres of land. (Thu, 01 Feb 2007 19:10:38 GMT)

DuPont to Open India Facility by 2008
DuPont said Thursday it plans on building a research and development center in India at a cost of about $22.5 million. (Thu, 01 Feb 2007 19:18:00 GMT)

DuPont to open India facility by 2008
The company said it signed a memorandum of understanding with ICICI Knowledge Park in Hyderabad, India, for a long-term lease that will give the company 15 acres of land. DuPont said it expects to break ground in March and expects the facility to be fully operational by early 2008. (Thu, 01 Feb 2007 19:25:07 GMT)

EU Sets Aside $650K to Hold Five Genomics Conferences in Europe
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Thu, 01 Feb 2007 20:14:47 GMT)

Illumina Reports Financial Results for Fourth Quarter 2006
SAN DIEGO----Illumina, Inc. announced today its financial results for the fourth quarter and fiscal year ended December 31, 2006. (Thu, 01 Feb 2007 21:02:00 GMT)

Life Scientists Embrace New Media
Life scientists rely on the Internet when conducting their research. A new study shows that they are increasingly turning to new digital information sources to find the products used in their labs. (Thu, 01 Feb 2007 21:18:00 GMT)

Ithaca, New York February 1, 2007 An international project led by Cornell University and the Boyce Thompson Institute ...
(BTI) at Cornell has received $1.8 million from the National Science Foundation (NSF) to continue sequencing the tomato genome and to create a database of genomic sequences and information on the tomato and related plants. (Thu, 01 Feb 2007 22:25:06 GMT)

Lockheed Martin Completes Acquisition of Management Systems Designers Incorporated
Lockheed Martin Corporation has completed its acquisition of Management Systems Designers Incorporated (MSD), a Fairfax, Virginia-based provider of information technology (IT) and scientific solutions supporting government life science, national security, and other civil agency missions. (Thu, 01 Feb 2007 23:08:47 GMT)

Biosite Incorporated Reports New Option Grants Under Nasdaq Marketplace Rule 4350
Biosite® Incorporated , today announced that, in accordance with Nasdaq Marketplace Rule 4350, 30 non-officer employees were granted inducement stock options covering an aggregate of 47,625 shares of common stock. (Thu, 01 Feb 2007 23:40:00 GMT)

February 1, 2007
The cooperative nature of barley research and improvement efforts was evident at the 36th Barley Improvement Conference at the Hacienda Hotel in San Diego, California, on Jan. 10-11. (Fri, 02 Feb 2007 00:54:46 GMT)

Life Scientists Embrace New Media
Life scientists rely on the Internet when conducting their research. A new study shows that they are increasingly turning to new digital information sources to find the products used in their labs. On average, respondents use four to five eMarketing channels to find information on research-related products. Overall, scientists prefer e-newsletters to email, discussion forums, e-zines, and other ... (Fri, 02 Feb 2007 01:26:36 GMT)

Life Scientists Embrace New Media
Life scientists rely on the Internet when conducting their research. A new study shows that they are increasingly turning to new digital information sources to find the products used in their labs. On average, respondents use four to five eMarketing channels to find information on research-related products. Overall, scientists prefer e-newsletters to email, discussion forums, e-zines, and other ... (Fri, 02 Feb 2007 01:40:37 GMT)

Education Briefs
Current 4-H members who are high school seniors or in their last year of 4-H are encouraged to apply for the 2007 Legacy of Leadership Scholarship. The application deadline for this merit-based award is March 1. (Fri, 02 Feb 2007 06:07:41 GMT)

Lockheed completes purchase of Management Systems Designers
Lockheed Martin completed its purchase Feb. 1 of Management Systems Designers (MSD), a Fairfax, Va.-based provider of information technology and scientific solutions. Terms of the transaction were not disclosed in the announcement. The acquisition was originally announced on Dec. 21, 2006. MSD specializes in systems design, development and integration; systems engineering; ... (Fri, 02 Feb 2007 08:11:37 GMT)

Whiteflies And Plant Viruses Can Help Each Other To Speed Up Biological Invasion
An invasive whitefly has developed mutualistic relationships with the plant viruses it transmits and is able to increase its population much faster on virus-infected plants than on healthy plants, whereas its indigenous counterpart is unable to do so, according to the new research carried out at Zhejiang University and Chinese Academy of Agricultural Sciences, China. (Fri, 02 Feb 2007 11:06:04 GMT)

Strategic Diagnostics to Present at Roth Capital Partners 2007 ''OC'' Growth Conference February 21, 2007
NEWARK, Del.----Strategic Diagnostics Inc. - a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, industrial, environmental and scientific applications, announced today that its President and Chief Executive Officer, Matthew Knight, will present at the Roth Capital Partners 2007 "OC" Growth Conference at 9:30 a.m. on February 21, 2007 in ... (Fri, 02 Feb 2007 13:10:00 GMT)

Cannibalism 'rife among prehistoric humans'
Genetic evidence from a tribe of former cannibals could suggest all our ancestors frequently ate one another (Fri, 02 Feb 2007 13:49:05 GMT)

Together, Biological Membranes Prevail
Researchers at the University of Illinois at Urbana-Champaign have developed a novel method to visualize the fusion of biological membranes at the single-event resolution. Observing the individual fusion events revealed an unprecedented detailed picture of membrane fusion, which was chronicled in one of the cover stories in the December 2006 issue of the journal Proceedings of National Academy of ... (Fri, 02 Feb 2007 14:05:34 GMT)

UC Riverside Boosts Collaborative Research With Powerful New SGI Altix Supercomputer
RIVERSIDE, Calif., Feb. 2 /PRNewswire-FirstCall/ -- At the University of California, Riverside, faculty and administrators understand the enormous value of collaborative research, in which investigators in one discipline work closely with researchers in other fields. (Fri, 02 Feb 2007 14:51:32 GMT)

Lockheed Martin buys Fairfax IT firm
Aerospace and defense contractor Lockheed Martin has completed its acquisition of Management Systems Designers, an information-technology company catering to the U.S. government. (Fri, 02 Feb 2007 16:13:14 GMT)

ReceptoPharm Expands Antiviral Clinical Research to South America
Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has today announced that its drug discovery division, ReceptoPharm, is expanding the clinical research of its lead antiviral drug candidate, RPI-MN, into South America. (Fri, 02 Feb 2007 17:12:04 GMT)

UC Riverside Boosts Collaborative Research With Powerful New SGI Altix Supercomputer
At the University of California, Riverside, faculty and administrators understand the enormous value of collaborative research, in which investigators in one discipline work closely with researchers in other fields. Such an approach can speed innovations that sharpen the technical edge of the university, of industry, and of America itself. (Fri, 02 Feb 2007 18:10:56 GMT)

Licensing contact
Osteoarthritis is chronic, often progressive and substantially disabling condition that becomes more common with advanced age. Osteoarthritis commonly involves the knees, hands, hips, neck and back resulting in pain and limitations of movement. (Fri, 02 Feb 2007 19:05:44 GMT)

Going whole hog- BAC map expedites swine genome sequence
Genome research is going to the hogs--and humans stand to benefit. A $10 million U.S. Department of Agriculture grant is enabling members of the Swine Genome Sequencing Consortium, an international coalition of researchers, to develop a draft sequence of the swine genome. (Fri, 02 Feb 2007 22:24:17 GMT)

UC Riverside Officials Inaugurate Supercomputer
The Bourns College of Engineering will be home for the Altix 4700, which will supercharge the pace of future research at UCR. (Sat, 03 Feb 2007 02:28:27 GMT)

ScienceBlogs Network Reviewed - Part 3: The D's
Science Blogs is a semi-professional network of people blogging about science. Most of them are in the university system as graduates or academics, but there is the odd journalist having their say. There are more than 50 blogs updated fairly regularly, and the network itself has been up for a year. This is part 3 of a continuing series of reviews (read part 1 , part 2 ). The following ... (Sat, 03 Feb 2007 03:09:28 GMT)

Newly discovered genes may lead to breeding new salt-tolerant wheat variety
Sydney, Feb 3 (ANI): A research team of the CSIRO's (Commonwealth Scientific and Industrial Research Organisation, Australia) Plant Industry has found that the two recently discovered genes - Nax1 and Nax2 - from an ancient wheat variety will lead to a major advance in breeding new salt-tolerant varieties. According to the finding of the study, the two genes work by excluding salt from different ... (Sat, 03 Feb 2007 08:42:14 GMT)

Pathways to growth
Taking UB from 25,000 to 35,000 students would happen faster with the help of the state, but Simpson believes the school can move ahead, regardless. "We surely can make some headway with what we have now," Simpson said. (Sat, 03 Feb 2007 13:59:39 GMT)

Rochester flexes its muscle at jazzed-up lobbying event
Lobbying expeditions to the State Capitol from regional centers are nothing new, but the Rochester crowd has kicked it up a notch. An event last week hosted by the Rochester Chamber of Commerce brought in more than 600 Rochesterians, who fanned out to attend committee meetings and buttonhole legislators. The event featured a very lively jazz band and rally in the rotunda and a "Grand Reception" ... (Sat, 03 Feb 2007 22:15:38 GMT)

Grafts Against Cancer
A research team led by Prof. Claude Perreault, Université de Montréal, is announcing a major discovery in Genomics. This will generate a fundamental impact on the treatment of blood cancers (leukemias and lymphomes) by means of peripheral blood T-cell grafts. [click link for full article] (Sun, 04 Feb 2007 05:04:07 GMT)

George Hohmann
The standard way to finance most university research is to get a grant, do the research, and then hope for more funding. Marshall University President Stephen Kopp said this is a particularly troublesome model if your research depends on state money. (Sun, 04 Feb 2007 05:05:48 GMT)

A bioscience edge needs effort
Partnerships have been struck. Gleaming new laboratories dedicated. Business incubators unfurled. And grant money awarded for research. For Minnesota's fledgling biosciences industry, what's next? Good question. Last month, scientists, academics and legislators dedicated a new research wing to the Vincent Stabile Building at the Mayo Clinic in Rochester. The $21.7 million laboratories are the ... (Sun, 04 Feb 2007 18:31:17 GMT)

Madhumathi D.S.
Bangalore Feb. 4 Big names, including Shapoorji Pallonji, L&T, DLF, IVRCL Infrastructure, Nagarjuna and Mahindra GESCO figure among the 16 developers that have bid for Bangalore's biotechnology park Helix. (Sun, 04 Feb 2007 19:56:51 GMT)

Biotech policy to give thrust on R&D
Department of Science & Technology and Department of Biotechnology are jointly planning a mission mode programme in biomaterial and medical devices to promote R&D and industrial activity, besides setting up a number of institutions for research to help the biotechnological sector emerge better in the country. (Mon, 05 Feb 2007 02:54:23 GMT)

OpenHelix Announces Free Trial Subscriptions to its Database of Tutorials on Genomics and Bioinformatics Resources
Life Science, biomedical researchers, and science librarians have free trial access to the OpenHelix database of tutorial suites on genomics and bioinformatics resources. This one-of-a-kind collection of on-line tutorials, with nearly 30 resources represented and more added frequently, gives life science and biomedical researchers the genomics knowledge they need, when they need it. (PRWeb Feb 5, ... (Mon, 05 Feb 2007 08:35:55 GMT)

Agendia announces a distribution agreement with Medvet Science, Australia.
Agendia B.V. and Medvet Science, the wholly owned subsidiary of the Institute of Medical and Veterinary Science, one of Australia's leading medical research organisations and a major provider of medical testing services to hospitals and the community in Australia, have entered into an exclusive distribution agreement for distribution of the MammaPrint breast cancer gene prognosis test in ... (Mon, 05 Feb 2007 08:48:00 GMT)

Bio-IT Briefs
February 05, 2007 | NextBio announced new features and content that give researchers and clinicians the ability to explore the world’s largest resource of experimental study results with more ease and security using the NextBio data search, store and share engine. (Mon, 05 Feb 2007 09:22:54 GMT)

Investigating The Invisible Life In Our Environment
A new computational method to analyse environmental DNA samples, developed by researchers at the European Molecular Biology Laboratory (EMBL) in Heidelberg, now sheds light on the microbial composition of different habitats, from soil to water. The study, which will be published in this week's online issue of the journal Science, also reveals that microbes evolve faster in some environments than ... (Mon, 05 Feb 2007 11:08:44 GMT)

Stratagene Acquires Rights to microRNA Sequences
LA JOLLA, Calif.----Stratagene Corporation , a developer, manufacturer and marketer of specialized life science research and diagnostic products, today announced that it has obtained the last of the four co-exclusive licenses to more than 150 microRNA sequences available from Max Planck Innovation, the technology transfer agency of the Max Planck Society. (Mon, 05 Feb 2007 11:30:00 GMT)

OpenHelix Announces Free Trial Subscriptions to its Database of Tutorials on Genomics and Bioinformatics Resources
Seattle, WA (PRWeb) February 4, 2007 -- OpenHelix announced today a program to give free access to researchers and scientists on its database of tutorial suites on genomic and bioinformatics resources. This one-of-a-kind collection of on-line tutorials, with nearly 30 resources represented and more added frequently, gives life science and biomedical researchers the genomics knowledge they need, ... (Mon, 05 Feb 2007 12:00:00 GMT)

Agendia Announces a Distribution Agreement With Medvet Science, Australia.
Agendia B.V. (Amsterdam, The Netherlands) and M (Mon, 05 Feb 2007 12:20:02 GMT)

United Press International ® News. Analysis. Insight.™
CAMPBELL, , Feb 05 (UPI) -- Australian scientists have used two recently discovered genes from an ancient wheat variety to develop a new way to breed salt-tolerant wheat. (Mon, 05 Feb 2007 12:39:37 GMT)

Scientists develop salt-tolerant wheat
Australian scientists have used two recently discovered genes from an ancient wheat variety to develop a new way to breed salt-tolerant wheat.Researchers say the two genes -- Nax1 and Nax2 -- work by excluding salt from different parts of the plant: one from the roots, the other from the leaves. The discovery of the two genes is the subject of international patents.The two genes originally came ... (Mon, 05 Feb 2007 12:40:40 GMT)

Agendia announces a distribution agreement with Medvet Science, Australia.
Agendia B.V. (Amsterdam, The Netherlands) and Medvet Science (Adelaide, Australia), the wholly owned subsidiary of the Institute of Medical and Veterinary Science, one of Australia's leading medical research organisations and a major provider of medical testing services to hospitals and the community in Australia, have entered into an exclusive distribution agreement for distribution of the ... (Mon, 05 Feb 2007 12:42:00 GMT)

Gene-IT Celebrates Successful 2006 New Business Results, Doubles GenomeQuest(TM) Customer Base
WESTBOROUGH, Mass.----Gene-IT, a leader in sequence search for research and IP, today announced that in 2006 the company had doubled its customer base for its flagship GenomeQuest integrated genomics search service, from 40 at year-end 2005 to 80 customers worldwide. (Mon, 05 Feb 2007 13:00:00 GMT)

ClearSpeed Technology to Accelerate South Africa's First National Supercomputer
BRISTOL, England----ClearSpeed Technology , the world leader in acceleration technology for high performance computing , today announced that the company is part of a $1.4 million contract to provide the first national supercomputer to South Africa's Centre for High Performance Computing . (Mon, 05 Feb 2007 14:00:00 GMT)

ACS News Service Weekly PressPac -- January 31, 2007
Here is the latest American Chemical Society (ACS) News Service Weekly press package (PressPac) with reports selected from 35 major peer-reviewed journals and Chemical & Engineering News. With more than 160,000 members, ACS is the world's largest scientific society. (Mon, 05 Feb 2007 14:09:07 GMT)

Luminex Corporation Fourth Quarter and Year-End 2006 Earnings Release Scheduled for February 7, 2007
Luminex Corporation today announced that it expects to report fourth quarter and year-end 2006 results on Wednesday, February 7, 2007. (Mon, 05 Feb 2007 15:00:00 GMT)

International Polar Year to Highlight Science at the Poles
February 2 - More than 200 scientific expeditions to the Arctic and Antarctic will be launched as part of International Polar Year, which begins in March. Scientists from more than 60 nations will collaborate on a range of activities during this international initiative. (Mon, 05 Feb 2007 15:37:27 GMT)

MIT 'microsieve' could aid study of diseases
CAMBRIDGE, Mass. -- A new MIT microchip system promises to speed up the separation and sorting of biomolecules such as proteins. (Mon, 05 Feb 2007 18:09:26 GMT)

MIT improves protein sorting with a new microchip
A new MIT microchip system promises to speed up the separation and sorting of biomolecules such as proteins. The work is important because it could help scientists better detect certain molecules, or biomarkers, associated with diseases, potentially leading to earlier diagnoses or treatments. (Mon, 05 Feb 2007 18:29:54 GMT)

Alzheimer's Gene Raises Newborns' Cerebral Palsy Risk
Apolipoprotein E (APOE), a gene associated with heightened risk for Alzheimer's disease in adults, can also increase the likelihood that brain-injured newborns will develop cerebral palsy, researchers at Children's Memorial Research Center have discovered. (Mon, 05 Feb 2007 19:08:30 GMT)

Stress Response Prevents Neurodegeneration
Multiple sclerosis (MS) is a debilitating immune-mediated disease of the brain and spinal cord (the central nervous system [CNS]). It is characterized by infiltration of the CNS by inflammatory cells and destruction of cells that reside in the CNS, known as oligodendrocytes (ODCs). The soluble factor IFN-gamma has a detrimental effect on disease in patients with MS. However, studies using the ... (Mon, 05 Feb 2007 19:09:12 GMT)

Scientists Identify Molecular Cause For One Form Of Deafness
Scientists exploring the physics of hearing have found an underlying molecular cause for one form of deafness, and a conceptual connection between deafness and the organization of liquid crystals, which are used in flat-panel displays. (Mon, 05 Feb 2007 19:09:47 GMT)

Beyond DNA: Chemical Signatures Reveal Genetic Switches In Genome
Investigators from the Ludwig Institute for Cancer Research (LICR) and the University of California, San Diego (UCSD) have made a breakthrough in identifying functional elements in the human genome, according to a report published online today in Nature Genetics. (Mon, 05 Feb 2007 19:10:09 GMT)

Announcing the Bioinformatics Franklin Award Nominees
January 31, 2007 | The Bioinformatics Organization has nominated four leading American scientists for the 2007 Benjamin Franklin Award. This year’s nominees are: (Mon, 05 Feb 2007 19:23:05 GMT)

Bio-IT Briefs
January 31, 2007 | Rep. Louise M. Slaughter (D-NY-28), Chairwoman of the House Rules Committee, on Tuesday advocated in support of the Genetic Information Non-discrimination Act (GINA - H.R. 493) before the Committee on Education and Labor's Subcommittee on Health, Employment, Labor, and Pensions. (Mon, 05 Feb 2007 19:23:15 GMT)

Seminar on 'Industrial Biotechnology: Gateway to Sustainable Future' at PU
A national seminar on 'Industrial Biotechnology: Gateway to Sustainable Future' was held at ICSSR Complex, Panjab University, today. The seminar was organised by Energy Research Centre (ERC), PU, in collaboration with the Indian Institute of Chemical Engineers (IIChE)- Chandigarh Regional Centre and sponsored by Department of Science and Technology, UT. PU Vice-Chancellor Prof RC Sobti ... (Mon, 05 Feb 2007 21:34:04 GMT)

Algae-Based Fuels Make a Comeback
It's time for a research resurgence into using small water plants to produce oil and ethanol. In Autopia. (Mon, 05 Feb 2007 22:44:10 GMT)

New Forecasting Tool Could Reduce Drug Development Costs
It now costs more than $800 million to develop a new drug. [click link for full article] (Tue, 06 Feb 2007 03:01:35 GMT)

NET SENSE: The Prize Economy
SAN FRANCISCO (Dow Jones) -- In a world where people are expected to labor for nothing, prizes have become the currency of choice. (Tue, 06 Feb 2007 05:37:56 GMT)

MIT 'microsieve' Could Aid Study Of Diseases
A new MIT microchip system promises to speed up the separation and sorting of biomolecules such as proteins. The work is important because it could help scientists better detect certain molecules, or biomarkers, associated with diseases, potentially leading to earlier diagnoses or treatments. [click link for full article] (Tue, 06 Feb 2007 09:01:25 GMT)

Synthematix, With Patents Pending, Products, Revenues and Experienced Management, Seeks $2 Million
DURHAM — Editor's note: Local Tech Wire's initial Top 25 Companies List will focus on emerging firms in North Carolina - those selected to present at CED's Venture 2002. Who are they? What are their products? Why should investors put money into their firms? (Tue, 06 Feb 2007 09:34:34 GMT)

DNAPrint Genomics AncestryByDNA(TM) Product Helps New York City Seventh Graders Learn About Their Pasts
DNAPrint Genomics, Inc., today announced the successful completion of an ancestry project involving five classes at Middle School 223, The Laboratory School of Finance and Technology in The Bronx, a New York City borough, that employed the Company's proprietary AncestryByDNA(TM) product and which rendered results that surprised some of the students and drew media attention. (Tue, 06 Feb 2007 12:00:00 GMT)

Matritech Reports Record Revenues for Fourth Quarter and Fiscal Year 2006
NEWTON, Mass.----Matritech , a leading developer and marketer of protein-based diagnostic products for the early detection of cancer, today reported financial results for the fourth quarter and fiscal year ended December 31, 2006. (Tue, 06 Feb 2007 12:00:00 GMT)

Celera to Webcast Presentation at BIO CEO & Investor Conference
ROCKVILLE, Md.----Celera , an Applera Corporation business, will webcast its presentation at the BIO CEO & Investor Conference on Tuesday, February 13, 2007. The presentation is scheduled to begin at 1:30 p.m. (Tue, 06 Feb 2007 12:00:00 GMT)

UPDATE on Affymetrix to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device ...
SANTA CLARA, Calif.----Affymetrix, Inc. wishes to issue the following update to its release BW5349 "Affymetrix to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference" issued Thursday, February 1, 2007: (Tue, 06 Feb 2007 14:00:00 GMT)

FDA Clears Breast Cancer Specific Molecular Prognostic Test
The MammaPrint test uses the latest in molecular technology to predict whether existing cancer will metastasize (spread to other parts of a patient's body). The test relies on microarray analysis, a powerful tool for simultaneously studying the patterns of behavior of large numbers of genes in biological specimens (Tue, 06 Feb 2007 14:51:30 GMT)

Bioscience sector subject of partnership
Buffalo BioSciences LLC and ECapital-Financing have announced a joint venture to assist bioscience companies in raising capital, optimizing product marketing, forming strategic alliances, and positioning interim management. (Tue, 06 Feb 2007 15:29:02 GMT)

New Microchip For Protein Sorting
A new MIT microchip system promises to speed up the separation and sorting of biomolecules such as proteins. The work is important because it could help scientists better detect certain molecules associated with diseases, potentially leading to earlier diagnoses or treatments (Tue, 06 Feb 2007 15:44:12 GMT)

Ancient Genes Used To Produce Salt-tolerant Wheat
Two recently discovered genes from an ancient wheat variety have led to a major advance in breeding new salt-tolerant varieties. (Tue, 06 Feb 2007 16:08:26 GMT)

Analyze the Major Technologies Used in the High Throughput Screening Industry
DUBLIN, Ireland----Research and Markets has announced the addition of High Throughput Screening to their offering. (Tue, 06 Feb 2007 17:00:00 GMT)

Examine Estimates and Projections for the World's Biomarkers Market
DUBLIN, Ireland----Research and Markets has announced the addition of Biomarkers Report to their offering. (Tue, 06 Feb 2007 17:25:00 GMT)

Examine the European and American Markets for ADME/Tox Technologies
DUBLIN, Ireland----Research and Markets has announced the addition of "ADME/Tox Technologies" to their offering. (Tue, 06 Feb 2007 18:00:00 GMT)

Human Skin Harbors Completely Unknown Bacteria
It appears that the skin, the largest organ in our body, is a kind of zoo and some of the inhabitants are quite novel, according to a new study. (Tue, 06 Feb 2007 18:08:24 GMT)

Eksigent Appoints Kevin Sayer to Board of Directors
DUBLIN, Calif.----Eksigent, a developer of advanced low-flow fluid delivery technologies for drug discovery and other life science applications, announced today that Kevin Sayer has been appointed to its board of directors. (Tue, 06 Feb 2007 18:18:00 GMT)

PENN Medicine News: Penn Awarded $2 Million Grant from Keck Foundation for Fundamental Research on Parkinson’s Disease
(PHILADELPHIA) – The University of Pennsylvania has received a $2 million grant from the W.M. Keck Foundation of Los Angeles for a pioneering study on the genomics of Parkinson's disease . The Keck Foundation’s program supports basic biomedical research and the development of pioneering new technologies. (Tue, 06 Feb 2007 18:21:01 GMT)

Clinically correct
Clinical research, as a distinct business model, is a relatively new phenomenon in India. (Tue, 06 Feb 2007 18:39:05 GMT)

Protein Stops HIV-1 In Its Tracks In Hematopoietic Stem Cells
Hematopoietic stem cells (HSCs) are one of the few cell types able to resist infection with HIV-1 despite expressing the cell surface molecules to which HIV-1 binds before entering a cell. In a study that appears in the February issue of the Journal of Clinical Investigation, researchers from Harvard Medical School, Boston, show that HSC expression of a protein known as p21Waf1/Cip1/Sdi1 (p21) is ... (Tue, 06 Feb 2007 19:07:54 GMT)

Human Proteins Evolving Slowly Thanks To Multitasking Genes
Many human proteins are not as good as they might be because the gene sequences that code for them have a double role which slows down the rate at which they evolve, according to new research published in PLoS Biology. (Tue, 06 Feb 2007 19:08:24 GMT)

What Makes Epithelial Cells Change Their Identity?
During development and during pathological processes in the adult, cells are constantly changing their function. One, well-characterized, cellular transition that occurs during development, as well as during wound healing, tissue fibrosis, and tumor metastasis, is the transition from an epithelial cell to a mesenchymal cell (often a fibroblast). (Tue, 06 Feb 2007 19:08:54 GMT)

FDA clears MammaPrint test for marketing
The Food and Drug Administration (FDA) has cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman's initial cancer. It is the first cleared molecular test that profiles genetic activity. (Tue, 06 Feb 2007 19:43:49 GMT)

FDA OKs Breast Cancer Recurrence Test
The FDA has approved a gene-based breast cancer test that helps tell early-stage breast cancer patients whether they need chemotherapy after surgery. (Wed, 07 Feb 2007 00:00:11 GMT)

The brains behind the bowl
Super Bowl XLII will require millions of sponsorship dollars and thousands of volunteers. But it also will require a vision and detailed game plan. Here are profiles of Arizona Super Bowl Host Committee executive board members and Glendale officials who are charged with the task of developing both. (Wed, 07 Feb 2007 00:04:36 GMT)

New exhibit details human origins
In the beginning were the bones. Fossils dating back hundreds of thousands- even millions- of years used by anthropologists to trace how the human species evolved. (Wed, 07 Feb 2007 00:36:31 GMT)

New Exhibit Details Human Origins
In the beginning were the bones. (Wed, 07 Feb 2007 00:36:31 GMT)

X PRIZE Opens Registration for Northrop Grumman Lunar Lander Challenge
X PRIZE today announced registration dates and rules changes for the $2 million Northrop Grumman Lunar Lander Challenge, which will require a vehicle to simulate trips between the moon's surface and lunar orbit. (Wed, 07 Feb 2007 01:37:47 GMT)

New exhibit details human origins
A new exhibition hall at the American Museum of Natural History is breaking ground by using fossils and genomics to tell the story of human development and evolution. (Wed, 07 Feb 2007 01:51:02 GMT)

New exhibit details human origins
In the beginning were the bones. Fossils dating back hundreds of thousands- even millions- of years used by anthropologists to trace how the human species evolved. (Wed, 07 Feb 2007 02:16:31 GMT)

Current Issue:
What research are you doing right now? I'm working with this program called CLIMB, Collaborative Learning at the Interface of Mathematics and Biology. It's a year-long research program in mathematical biology and we cover a lot of subjects. (Wed, 07 Feb 2007 08:10:53 GMT)

New test shows which breast cancers will recur
Approval has been granted by the FDA for a gene-based test that helps tell early-stage breast cancer patients whether they need chemotherapy after their surgery. (Wed, 07 Feb 2007 10:43:47 GMT)

TWO NEW 'SUGAR PROBES' FOR CANCER SPREAD DEVELOPED
Taipei, Feb. 7 (CNA) Researchers at Academia Sinica's Genomics Research Center have developed two new "sugar probes" that can target abnormal proteins in cancer cells to facilitate studies on cancer metastasis, academic sources said Wednesday. (Wed, 07 Feb 2007 10:50:55 GMT)

Acacia Technologies Licenses Image Resolution Enhancement Technology to Lexmark
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that IP Innovation, LLC a wholly owned subsidiary that is a part of the Acacia Technologies group, has entered into a License Agreement with Lexmark International, Inc. covering patents that apply to Image Resolution Enhancement Technology. (Wed, 07 Feb 2007 11:00:00 GMT)

FDA Clears Breast Cancer Specific Molecular Prognostic Test
The U.S. Food and Drug Administration (FDA) today cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman's initial cancer. It is the first cleared molecular test that profiles genetic activity. (Wed, 07 Feb 2007 11:07:39 GMT)

Acacia Technologies Licenses Image Resolution Enhancement Technology to Lexmark
NEWPORT BEACH, Calif., (Wed, 07 Feb 2007 12:23:25 GMT)

Matritech, Inc. (AMEX: MZT) Q4/06 Review Issued by Scimitar Equity Research, Inc.
Scimitar Equity Research, Inc. issues a review on Matritech, Inc. entitled ""Encouraging Q4 and FY06 Results, Financing, AMEX Compliance and FY07 Guidance". (Wed, 07 Feb 2007 14:41:00 GMT)

Loss of a universal tRNA feature reported
Blacksburg, Va. – Scientists at the Virginia Bioinformatics Institute (VBI) report in the Journal of Bacteriology that two alphaproteobacteria lack the universal extra guanylate nucleotide typically found in the transfer RNA molecule tRNAHis. tRNAs are the molecules responsible for decoding sequence information specified by messenger RNA molecules, information which is ultimately encoded by the ... (Wed, 07 Feb 2007 15:03:50 GMT)

Enzo Biochem Life Sciences Unit Awarded Two Patents That Enhance Competitive Position of Existing Products For ...
NEW YORK----Enzo Biochem, Inc. announced today that its subsidiary, Enzo Life Sciences, Inc., has been granted two new patents by the U.S. Patent and Trademark Office that will complement and strengthen existing proprietary labeling products for the genomics and diagnostics markets. (Wed, 07 Feb 2007 15:30:00 GMT)

FDA approves molecular breast cancer test
The U.S. Food and Drug Administration has approved a test that determines the likelihood of breast cancer returning within 10 years after treatment.The specific molecular prognostic test is the first FDA-approved molecular test that profiles genetic activity.The MammaPrint test uses molecular technology to predict whether existing cancer will metastasize. The test relies on microarray analysis, a ... (Wed, 07 Feb 2007 15:40:20 GMT)

United Press International ® News. Analysis. Insight.™
WASHINGTON, Feb. 7 (UPI) -- The U.S. Food and Drug Administration has approved a test that determines the likelihood of breast cancer returning within 10 years after treatment. (Wed, 07 Feb 2007 15:54:45 GMT)

Enzyme Wakes Sleeping Genes
Scientists at the German Cancer Research Center discover an enzyme that activates epigenetically silenced genes. For several years now, cancer researchers have been studying a mechanism that contributes to the development of malignant tumors: The cell attaches small molecules containing a carbon atom, called methyl groups, to specific building blocks of DNA, thereby individually switching off the ... (Wed, 07 Feb 2007 16:07:54 GMT)

Horse Genome Assembled: Thoroughbred Mare's DNA Code Now Freely Available
The first draft of the horse genome sequence has been deposited in public databases and is freely available for use by biomedical and veterinary researchers around the globe, leaders of the international Horse Genome Sequencing Project announced today. (Wed, 07 Feb 2007 16:08:24 GMT)

Law Firm Asks USPTO to Reexamine Two OGT Microarray Patents
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 07 Feb 2007 19:21:48 GMT)

Loss of a universal tRNA feature
Scientists at the Virginia Bioinformatics Institute (VBI) report in the Journal of Bacteriology that two alphaproteobacteria lack the universal extra guanylate nucleotide typically found in the transfer RNA molecule tRNAHis. (Wed, 07 Feb 2007 19:59:18 GMT)

FDA Approves Molecular Breast Cancer Test
The U.S. Food and Drug Administration has approved a test that determines the likelihood of breast cancer returning within 10 years after treatment. The specific molecular prognostic test is the first FDA-approved molecular test that profiles genetic activity. (Wed, 07 Feb 2007 20:19:58 GMT)

FDA OKs Breast Cancer Recurrence Test
Title: FDA OKs Breast Cancer Recurrence Test Category: Health News Created: 2/7/2007 Last Editorial Review: 2/7/2007 (Wed, 07 Feb 2007 20:36:20 GMT)

Luminex Corporation Reports Fourth Quarter and Year-End 2006 Results
Luminex Corporation today announced financial results for the fourth quarter and year ended December 31, 2006. (Wed, 07 Feb 2007 21:01:00 GMT)

Affymetrix Reports Fourth Quarter and Fiscal Year 2006 Results
SANTA CLARA, Calif.----Affymetrix Inc., today reported its operating results for the fourth quarter and fiscal year ended December 31, 2006. On a GAAP basis, the Company reported net income of approximately $8.7 million or $0.13 per diluted share in the fourth quarter of 2006 as compared to net income of $30.6 million or $0.43 per diluted share in the fourth quarter of 2005. (Wed, 07 Feb 2007 21:31:00 GMT)

Affymetrix's Q4 profit falls to $8.7M
Affymetrix Inc. on Wednesday reported fourth quarter net income of $8.7 million, or 13 cents a share, compared to the year-ago period's $30.6 million, or 43 cents a share. (Wed, 07 Feb 2007 22:05:33 GMT)

Affymetrix fourth-quarter net falls
NEW YORK (MarketWatch) -- Affymetrix Inc. said fourth-quarter net earnings fell to $8.7 million, or 13 cents a share, from year-earlier profit of $30.6 million, or 43 cents a share. (Wed, 07 Feb 2007 22:40:39 GMT)

United Press International ® News. Analysis. Insight.™
SEVILLE, Spain, Feb. 7 (UPI) -- Spanish medical researchers say they have discovered a new potential benefit of olive oil for people suffering from peptic ulcer disease. (Wed, 07 Feb 2007 22:53:45 GMT)

UPI NewsTrack Health and Science News
New medical use for olive oil suggestedSEVILLE, Spain, Feb. 7 (UPI) -- Spanish medical researchers say they have discovered a new potential benefit of olive oil for people suffering from peptic ulcer disease.The scientists say extra virgin olive oil -- already providing an array of health benefits -- might help prevent and treat Helicobacter pylori infections, which cause millions of cases of ... (Wed, 07 Feb 2007 23:40:08 GMT)

CITY SCIENCE COULD SAVE LIVES
Scientists from Complement Genomics are set to make a breakthrough in genetic tests which could predict the risk of deep vein thrombosis (DVT), a condition that kills about 20,000 people every year. (Thu, 08 Feb 2007 03:25:11 GMT)

United Press International ® News. Analysis. Insight.™
SEVILLE, Spain, Feb. 7 (UPI) -- Spanish medical researchers say they have discovered a new potential benefit of olive oil for people suffering from peptic ulcer disease. (Thu, 08 Feb 2007 04:09:25 GMT)

CEO Radio Network Announces Interviews with Executives of Debt Resolve and Power3 Medical Products, Inc.
The CEO Radio Network is pleased to announce that it has posted exclusive interviews with the following companies on the www. (Thu, 08 Feb 2007 07:01:00 GMT)

Fresh Starts: Entrepreneurs To Debut in New Roles at Luncheon
RESEARCH TRIANGLE — Editor's note: BioWatch is a regular feature on Fridays. Two spinouts from Triangle Universities led by locally well-known serial entrepreneurs present at the Council for Entrepreneurial Development's Capital Connection luncheon on Sept. 10. (Thu, 08 Feb 2007 07:04:34 GMT)

US FDA clears breast cancer test
The US Food and Drug Administration (FDA) cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman's initial cancer. It is the first cleared molecular test that profiles genetic activity. (Thu, 08 Feb 2007 07:39:42 GMT)

FDA clears genomic test for breast cancer
WASHINGTON, D.C. – Feb. 8, 2007 – A new test that determines the likelihood of cancer returning within five to 10 years after treatment for breast cancer was given a thumbs up by the FDA yesterday. (Thu, 08 Feb 2007 08:35:56 GMT)

CEO Radio Network Announces Interviews with Executives of Debt Resolve and Power3 Medical Products, Inc.
The CEO Radio Network is pleased to announce that it has posted exclusive interviews with the following companies on the www.ceoradionetwork.com website: Debt Resolve (AMEX:DRV) and Power3 Medical Products, Inc. (PWRM.PK). DRV: Chairman and Chief Executive Officer James Burchetta discusses Debt Resolve's patented online bidding system for the resolution of debt. PWRM: Chairman and Chief ... (Thu, 08 Feb 2007 08:40:38 GMT)

Giving tired hearts a chance to rest
Cardiac surgeon Steven Bolling was out running one day, thinking about dinosaurs. As a parent of an 8-year-old boy, he often had prehistoric creatures on his mind, if only because thousands of plastic ones were under foot at home. (Thu, 08 Feb 2007 11:04:45 GMT)

FDA Approves Gene-Based Breast Cancer Test
The U.S. Food and Drug Administration approved on Tuesday a new genetic test that's designed to determine the likelihood that early stage breast cancer will recur within five to 10 years after treatment. (Thu, 08 Feb 2007 11:09:08 GMT)

Prematurity More Accurately Predicted by Advances in Proteomic Technology
New Haven, Conn. (Thu, 08 Feb 2007 13:22:43 GMT)

Breast Cancer Recurrence Risk Test Cleared For Marketing
The U.S. Food and Drug Administration (FDA) has cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman's initial cancer. It is the first cleared molecular test that profiles genetic activity. (Thu, 08 Feb 2007 15:12:56 GMT)

Artificial Cells To Fight Disease?
Carnegie Mellon University's Philip Leduc predicts the use of artificially created cells could be a potential new therapeutic approach for treating diseases in an ever-changing world. (Thu, 08 Feb 2007 15:13:16 GMT)

Reports Of Prognostic Tumor Markers Often Inadequate
Reports of studies of cancer prognostic factors are largely suboptimal, a new study concludes. (Thu, 08 Feb 2007 15:14:13 GMT)

Strategic Diagnostics Names Beijing Green Science and Technology as Exclusive Distribution Partner for Water Quality ...
NEWARK, Del.----Strategic Diagnostics Inc. - a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, industrial, environmental and scientific applications, and the Beijing Green Science and Technology Company today recognized the successful completion of their first year of collaboration and confirmed that Beijing Green will continue to be ... (Thu, 08 Feb 2007 16:37:00 GMT)

United Press International ® News. Analysis. Insight.™
SEVILLE, Spain, Feb. 7 (UPI) -- Spanish medical researchers say they have discovered a new potential benefit of olive oil for people suffering from peptic ulcer disease. (Thu, 08 Feb 2007 16:38:58 GMT)

Nanotechnology meets biology and DNA finds its groove
The object of fascination for most is the DNA molecule. But in solution, DNA, the genetic material that hold the detailed instructions for virtually all life, is a twisted knot, looking more like a battered ball of yarn than the famous double helix. To study it, scientists generally are forced to work with collections of molecules floating in solution, and there is no easy way to precisely single ... (Thu, 08 Feb 2007 18:24:26 GMT)

Autism May Be More Prevelant Than Previous Estimates
The Centers for Disease Control and Prevention (CDC) reported findings today from the first and largest summary of prevalence data from multiple U.S. communities participating in an autism spectrum disorder (ASD) surveillance project. The results showed an average of 6.7 children out of 1,000 had an ASD in the six communities assessed in 2000, and an average of 6.6 children out of 1,000 having an ... (Thu, 08 Feb 2007 19:11:36 GMT)

Foolish Forecast: LabCorp Tests Positive
A major new contract bodes well for the lab-testing firm's future. (Thu, 08 Feb 2007 20:54:42 GMT)

1 2 3 4 Next

Home | News | Companies | Tutorials | Books | Jobs | Directory | What's Bioinformatics | Bioinformatics FAQ
© Copyright by ColorBasePair.com. All rights reserved.